Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity.
Kalle GehringHiroaki MikiPublished in: British journal of cancer (2020)
Phosphatases of regenerating liver (PRL1-3) are among the most oncogenic protein phosphatases but their mechanism of action is poorly understood. Multiple substrates have been proposed as well as a non-catalytic function regulating magnesium transport. Our recent identification of a catalytically inactive PRL mutant that retains oncogenicity in a mouse model promises to resolve the question of whether PRLs act as phosphatases or pseudo-phosphatases in different cancer models.